Phase 2 Trial Using Talampanel in Patients With Recurrent High Grade Gliomas

- Glioblastoma Multiforme|Anaplastic: Astrocytoma,Oligodendroglioma|Anaplastic Mixed Oligoastrocytoma
- Terminated

Study Title: Phase 2 Trial Using Talampanel in Patients With Recurrent High Grade Gliomas

Teva Identifier: IXR-205-21-189

ClinicalTrials.gov Identifier: NCT00062504

Study Status: Terminated

Trial Condition(s): Glioblastoma Multiforme|Anaplastic: Astrocytoma,Oligodendroglioma|Anaplastic Mixed Oligoastrocytoma

Interventions: Drug: Talampanel

Study Description

Please refer to ClinicalTrials.gov for a description of the trial

Participation criteria and map of study locations

Key Participation Requirements

Gender: Female, Male

Age group: Adult, Older Adult

Age Range: 18 Years and older

Trial Duration: 07/01/2003 - 04/01/2006

Phase: Phase 2

Study Type

Interventional